An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss. - Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL (Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research, 2015)